Lippincott-Raven Publishers, Philadelphia © International League Against Epilepsy Remacemide Hydrochloride and ARL 15896AR Lack Abuse Potential: Additional Differences from Other Uncompetitive NMDA Antagonists
Thomas J. Hudzik, Louis Freedman, Gene C. PalmerVolume:
37
Year:
1996
Language:
english
Pages:
7
DOI:
10.1111/j.1528-1157.1996.tb00607.x
File:
PDF, 692 KB
english, 1996